NASDAQ:HZNP Horizon Therapeutics Public - HZNP Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Horizon Therapeutics Public Limited Please log in to your account or sign up in order to add this asset to your watchlist. $109.17 +0.65 (+0.60%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$108.63▼$109.2650-Day Range$107.32▼$113.1152-Week Range$57.84▼$117.49Volume1.70 million shsAverage Volume2.48 million shsMarket Capitalization$24.94 billionP/E Ratio48.96Dividend YieldN/APrice Target$111.42 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Horizon Therapeutics Public (NASDAQ:HZNP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$49,669.15Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$67.96 M HZNP Insider Buying and Selling by Quarter Get HZNP Insider Trade Alerts Want to know when executives and insiders are buying or selling Horizon Therapeutics Public stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Horizon Therapeutics Public Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails1/17/2023Andy PasternakEVPSell27,129$113.03$3,066,390.8756,338 1/13/2023Aaron CoxCFOSell36,148$113.17$4,090,869.16277 1/10/2023Jeffrey W ShermanEVPSell3,368$113.05$380,752.4039,539 1/6/2023Jeffrey W ShermanEVPSell5,187$113.29$587,635.2349,314 12/12/2022Jeffrey W ShermanEVPSell28,352$111.45$3,159,830.4054,501 8/4/2022Sean M ClaytonEVPBuy745$66.67$49,669.15745 7/29/2022Andy PasternakEVPSell4,850$82.57$400,464.5034,047 7/19/2022Elizabeth H.Z. ThompsonEVPSell90$85.04$7,653.6012,886 7/7/2022Elizabeth H.Z. ThompsonEVPSell82$85.01$6,970.8212,976 6/10/2022Andy PasternakEVPSell762$85.36$65,044.3238,897 6/3/2022Timothy P WalbertCEOSell25,000$92.34$2,308,500.00435,826 5/31/2022Timothy P WalbertCEOSell25,000$92.48$2,312,000.00435,549 5/20/2022Timothy P WalbertCEOSell25,000$90.00$2,250,000.00460,549 5/11/2022Timothy P WalbertCEOSell17,600$90.00$1,584,000.00460,549 5/6/2022Timothy P WalbertCEOSell7,400$90.86$672,364.00460,549 4/22/2022Timothy P WalbertCEOSell25,000$106.59$2,664,750.00485,549 4/20/2022Paul W HoelscherCFOSell50,000$114.71$5,735,500.001,049 4/12/2022Michael A DesjardinEVPSell20,214$113.12$2,286,607.6882,346 4/8/2022Timothy P WalbertCEOSell25,000$112.38$2,809,500.00485,549 4/6/2022Jeffrey W ShermanEVPSell42,009$110.02$4,621,830.1810,629 4/6/2022Paul W HoelscherCFOSell215,335$110.01$23,689,003.351,049 3/30/2022Timothy P WalbertCEOSell50,000$105.26$5,263,000.00 (Data available from 1/1/2013 forward) HZNP Insider Trading Activity - Frequently Asked Questions Who is on Horizon Therapeutics Public's Insider Roster? The list of insiders at Horizon Therapeutics Public includes Aaron Cox, Andy Pasternak, Barry Moze, Brian K Beeler, Daniel A Camardo, Elizabeth H.Z. Thompson, Geoffrey M Curtis, Irina Konstantinovsky, Jeff Kent, Jeffrey W Sherman, Michael A Desjardin, Michael G Grey, Miles W Mchugh, Paul W Hoelscher, Sean M Clayton, Timothy P Walbert, Vikram Karnani, and William F Daniel. Learn more on insiders at HZNP. What percentage of Horizon Therapeutics Public stock is owned by insiders? 2.50% of Horizon Therapeutics Public stock is owned by insiders. Learn more on HZNP's insider holdings. Which Horizon Therapeutics Public insiders have been buying company stock? The following insider purchased HZNP shares in the last 24 months: Sean M Clayton ($49,669.15). How much insider buying is happening at Horizon Therapeutics Public? Insiders have purchased a total of 745 HZNP shares in the last 24 months for a total of $49,669.15 bought. Which Horizon Therapeutics Public insiders have been selling company stock? The following insiders have sold HZNP shares in the last 24 months: Aaron Cox ($4,090,869.16), Andy Pasternak ($10,521,634.66), Barry Moze ($9,082,865.52), Brian K. Beeler ($3,036,911.13), Daniel A Camardo ($1,102,950.00), Elizabeth H.Z. Thompson ($816,640.70), Geoffrey M Curtis ($6,614,803.89), Jeffrey W Sherman ($13,839,858.21), Michael A Desjardin ($2,286,607.68), Michael G Grey ($1,854,400.00), Paul W Hoelscher ($33,310,583.35), Timothy P Walbert ($59,757,614.00), and William F Daniel ($1,731,200.00). How much insider selling is happening at Horizon Therapeutics Public? Insiders have sold a total of 1,542,306 Horizon Therapeutics Public shares in the last 24 months for a total of $157,311,217.55 sold. This page (NASDAQ:HZNP) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.